StockWatch
·
Computers - Software & Consulting
Board Meeting31 Oct 2026, 02:00 pm

iSERA Lifesciences Board Meeting on Nov 4 to Approve Un-Audited Results

AI Summary

iSERA Lifesciences Ltd has announced that its Board of Directors will convene on November 4, 2026, to consider and approve the standalone un-audited financial results for the quarter and half-year ended September 30, 2026. Concurrently, the trading window for designated persons will be closed from October 1, 2026, until 48 hours after the results are declared, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 4, 2026.
  • To approve un-audited financial results for Q2 FY27 and H1 FY27.
  • Trading window closure effective October 1, 2026.
  • Closure period extends 48 hours post-results declaration.